|
|
||||||||
American Journal of Clinical Nutrition, Vol 50, 962-969, Copyright © 1989 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
SP Donahue and LS Phillips
Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303.
IGF-1 is a circulating growth factor with hepatic release dependent on nutritional status. To determine if IGF-1 could be a useful nutritional index, 15 malnourished patients were assessed during nutritional support. Patients with protein or protein-calorie malnutrition had lower IGF-1 (39 +/- 7 micrograms/L) than did patients with calorie-only malnutrition (109 +/- 25 micrograms/L, p less than 0.005); transferrin concentrations did not differ between the two groups. Nutritional supplementation produced an increase in IGF-1 (123 +/- 32 micrograms/L, p less than 0.005); the relative increase in IGF-1 (264 +/- 62%, p less than 0.001) exceeded increases in albumin or transferrin (9 +/- 6% and 59 +/- 16%, NS and p less than 0.005, respectively). Reduction or termination of support was followed by a decrease in IGF-1 to 59 +/- 9% of peak values (p less than 0.001) but neither albumin nor transferrin decreased significantly. Changes in IGF-1 were correlated with nitrogen balance (r = 0.45, p less than 0.005). The strong relationship between IGF-1 and nutritional status suggests that IGF-1 determinations may be useful in guiding nutritional therapy in patients whose nitrogen balance is difficult to assess.
This article has been cited by other articles:
![]() |
A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Ballard, J. A Clapper, B. L Specker, T. L Binkley, and M. D Vukovich Effect of protein supplementation during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Sermet-Gaudelus, J C Souberbielle, I Azhar, J C Ruiz, P Magnine, V Colomb, C Le Bihan, D Folio, and G Lenoir Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients Arch. Dis. Child., November 1, 2003; 88(11): 956 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kritsch, S. Murali, M. L. Adamo, and D. M. Ney Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R528 - R536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hotta, I. Fukuda, K. Sato, N. Hizuka, T. Shibasaki, and K. Takano The Relationship between Bone Turnover and Body Weight, Serum Insulin-Like Growth Factor (IGF) I, and Serum IGF-Binding Protein Levels in Patients with Anorexia Nervosa J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 200 - 206. [Abstract] [Full Text] |
||||
![]() |
G. GAYAN-RAMIREZ, F. VANDERHOYDONC, G. VERHOEVEN, and M. DECRAMER Acute Treatment with Corticosteroids Decreases IGF-1 and IGF-2 Expression in the Rat Diaphragm and Gastrocnemius Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 283 - 289. [Abstract] [Full Text] |
||||
![]() |
L. E. Underwood Special Considerations in the Design of Trials Involving Children J. Nutr., January 1, 1999; 129(1): 264S - 264S. [Full Text] [PDF] |
||||
![]() |
W. J. Smith, L. E. Underwood, L. Keyes, and D. R. Clemmons Use of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein Measurements to Monitor Feeding of Premature Infants J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3982 - 3988. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |